House Bill No. 813 aims to enhance the prescribing, administering, and dispensing of FDA-approved drugs for off-label use by licensed healthcare professionals in Louisiana. The bill enacts R.S. 37:1704, which explicitly states that no healthcare professional licensing board or commission can prohibit or restrict the off-label use of a human drug that has been FDA-approved during a declared public health emergency. The bill also defines "off-label use" as the use of a prescription drug for indications, age groups, dosages, or routes of administration that have not received FDA approval.

Additionally, the bill includes amendments that remove the Louisiana Department of Health from the list of entities that could impose restrictions on off-label drug use. It reinforces that during a public health emergency, healthcare professionals are permitted to prescribe, administer, or dispense FDA-approved drugs without facing limitations from licensing boards or commissions. This legislative change is intended to facilitate more flexible healthcare responses in times of crisis.